Table 2.
Influence of ACEI or ARB use on Death Rate and AKI.
| Parameter | No therapy with ACEI/ARB | Therapy with ACEI/ARB | P-value | RR (95% CI) | |
|---|---|---|---|---|---|
| Death | |||||
| No | n% | 65 (77.38%) | 32 (88.89%) | .21 | 0.49 (0.18; 1.34) |
| Yes | n% | 19 (22.62%) | 4 (11.11%) | ||
| Death (Hypertension only) | |||||
| No | n% | 31 (64.58%) | 27 (87.10%) | .04 | 0.36 (0.14; 0.98) |
| Yes | n% | 17 (35.42%) | 4 (12.90%) | ||
| Death (Diabetes only) | |||||
| No | n% | 18 (69.23%) | 14 (93.33%) | .12 | 0.22 (0.03; 1.57) |
| Yes | n% | 8 (30.77%) | 1 (6.67%) | ||
| Death (Diabetes and Hypertension) | |||||
| No | n% | 17 (68.00%) | 14 (93.33%) | .12 | 0.21 (0.03; 1.51) |
| Yes | n% | 8 (32.00%) | 1 (6.67%) | ||
| AKI | |||||
| No | n% | 61 (72.62%) | 22 (61.11%) | .28 | 0.84 (0.63; 1.13) |
| Yes | n% | 23 (27.38%) | 14 (38.89%) |
ACEI/ARB = angiotensin-converting enzyme inhibitor/angiotensin receptor blocker, AKI = acute kidney injury, RR = risk ratio, CI = confidence interval.